Latest News About - reusuable devices

 
Show/hide duplicate news articles.
Filter by countryfromabout
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Thursday, January 18, 2018

2:20:00 PM CET

Subscribe
RSS | MAP

Language Selection

For any category/filter, users can choose:

  1. the language of the categorized news items (e.g. fr and de to display only those news items in French and German)
  2. the language of the user interface (e.g. it for Italian)

In Top Stories, the user can display the largest clusters of news items for one language only (e.g. en shows all clusters in English)

Country Selection

Users can choose:

  1. country mentioned in the news item (articles about a country)
  2. country in which the news item was published (articles from a country)

Languages Collapse menu...Expand menu...Open help...

Select your languages

ar
az
be
bg
bs
ca
cs
da
de
el
en
eo
es
et
fa
fi
fr
ga
ha
he
hi
hr
hu
hy
id
is
it
ja
ka
km
ko
ku
lb
lo
lt
lv
mk
ml
mt
nl
no
pap
pl
ps
pt
ro
ru
rw
se
si
sk
sl
sq
sr
sv
sw
ta
th
tr
uk
ur
vi
zh
all
Show additional languagesHide additional languages

Interface:

Quotes... Extracted quotes

Paul Anderson said: “This is an important addition to our current global IP portfolio. Not only does it further strengthen our IP position in regenerative medicine products and surgical techniques for soft tissue repair, but it also acts to validate CelGro as a collagen medical device platform, for use across multiple indications including bone, tendons, peripheral nerves and aid in the repair of spinal cord injuries. This comes at a perfect time for the company as we move our products through the registration processes in the US” External link

4-traders Thursday, January 18, 2018 1:53:00 AM CET

Keith Stewart said: "Results from the final analysis of the Phase 3 ASPIRE trial published today in the Journal of Clinical Oncology are significant, as they further validate carfilzomib, lenalidomide and dexamethasone as a standard of care regimen for patients with relapsed or refractory multiple myeloma," External link

prnewswire Wednesday, January 17, 2018 10:31:00 PM CET

David Mercado stated: "This partnership allows us to better support the rapidly evolving needs of our customers and accelerate innovation in the area of personalized medicine," External link

4-traders Wednesday, January 17, 2018 3:19:00 PM CET

Steve Womack said: “It’s a strategy that we think is a winning formula,” “I mean, when you think about medical device tax, Cadillac tax, health insurance tax, voting against the CR, voting against funding our troops — those are really difficult positions to maintain if you’re the other side” External link

politico Wednesday, January 17, 2018 4:32:00 AM CET

Joe Kiani said (about Bill Clinton): “We are thrilled to have President Clinton continue this journey with us to eliminate preventable patient deaths in our hospitals,” External link

4-traders Tuesday, January 16, 2018 8:38:00 PM CET

Frank Yu said: “LifeTech has a proven track record in commercializing innovative medical devices in China and overseas, and in collaborating with global medtech companies in localizing world-class products in China, which is increasingly critical for foreign technologies entering into China,” External link

padovanews Wednesday, January 10, 2018 10:10:00 PM CET

Mattias Perjos säger: ”Dagens tillkännagivande är en viktig milstolpe i de tekniska satsningar som Getinge gör för att kunna erbjuda våra kunder toppmoderna lösningar för sina patienter. Som en global ledare inom medicinteknik är Getinge stolt över att få samarbeta med Verb för att driva forskning och innovation framåt och förändra den medicinska industrins framtid, samtidigt som vi för vårt arv vidare som leverantör av kompletta lösningar” External link

DagensIndustri Thursday, November 30, 2017 11:09:00 PM CET

Most associated names

Daily number of articles in this category

Trend data not available for this selection.